These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1760817)

  • 1. Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K.
    Yefenof E; Einat E; Klein E
    Cancer Immunol Immunother; 1991; 34(2):133-7. PubMed ID: 1760817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.
    Yefenof E; Gafanovitch I; Oron E; Bar M; Klein E
    Cancer Immunol Immunother; 1995 Dec; 41(6):389-96. PubMed ID: 8635197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.
    Yefenof E; Meidav A; Kedar E
    J Exp Med; 1980 Dec; 152(6):1473-83. PubMed ID: 6256461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity and suppression in radiation- and radiation leukemia virus (RadLV)-induced leukemogenesis.
    Yefenof E; Ben-David Y
    Leuk Res; 1986; 10(7):797-801. PubMed ID: 2942733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of T-cell proliferation by PSK.
    Hirai R; Oguchi Y; Sugita N; Matsunaga K; Nomoto K
    Int J Immunopharmacol; 1993 Aug; 15(6):745-50. PubMed ID: 8407056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis.
    Yefenof E; Ben-David Y
    Cancer Immunol Immunother; 1983; 16(1):48-52. PubMed ID: 6227381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High- and low-leukemogenic variants of the radiation leukemia virus (RadLV): immunogenic, suppressive and genetic properties in relation to leukemogenic activity.
    Yefenof E; Ben David Y; Kotler M
    Int J Cancer; 1984 Dec; 34(6):875-82. PubMed ID: 6439654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.
    Lonai P; Katz E; Peled A; Haran-Ghera N
    Immunogenetics; 1981 Mar; 12(5-6):423-32. PubMed ID: 6260638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
    Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antitumor cytotoxicity of hepatic lymphocytes by oral administration of PSK.
    Yunoki S; Tanaka N; Hizuta A; Orita K
    Int J Immunopharmacol; 1994 Feb; 16(2):123-30. PubMed ID: 8181901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of IL-4 secretion by the radiation leukemia virus (RadLV): role in autocrine growth stimulation of RadLV infected pre-leukemic cells.
    Yefenof E; Ela C; Kotler M; Vitetta ES
    Int J Cancer; 1992 Feb; 50(3):481-5. PubMed ID: 1735616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Imai S; Tobe T
    Cancer Immunol Immunother; 1991; 32(6):335-41. PubMed ID: 1901030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro.
    Okuzawa M; Shinohara H; Kobayashi T; Iwamoto M; Toyoda M; Tanigawa N
    Int J Oncol; 2002 Jun; 20(6):1189-95. PubMed ID: 12011998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A suppressive effect of PSK, a protein-bound polysaccharide preparation, on tumor growth: a new effect of PSK on cell motility].
    Katano M; Yamamoto H; Torisu M
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2321-6. PubMed ID: 3606151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of immune responsiveness by a biological response modifier, PSK, in aged mice bearing syngeneic transplantable tumor.
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1987 Nov; 24(3):143-9. PubMed ID: 3430562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.
    Meruelo D
    J Exp Med; 1979 Apr; 149(4):898-909. PubMed ID: 219130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell lymphoma induction by radiation leukemia virus in athymic nude mice.
    Ricciardi-Castagnoli P; Lieberman M; Finn O; Kaplan HS
    J Exp Med; 1978 Nov; 148(5):1292-310. PubMed ID: 214507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
    Fisher M; Yang LX
    Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cells.
    Vánky F; Wang P; Klein E
    Cancer Immunol Immunother; 1992; 35(3):193-8. PubMed ID: 1638556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.